Etiology of Hyperprolactinemia
Causes of Hyperprolactinemia
- Hyperprolactinemia can be caused by multiple factors, including prolactinomas, medications that antagonize dopamine, primary hypothyroidism, renal or hepatic disease, and the effect of compression of the pituitary stalk, according to the Endocrine Society 1, 2, 3
- The levels of prolactin vary with age and sex, being higher in the first 2 years of life, decreasing in mid-childhood, and increasing again in adolescence, with higher levels in girls than in boys, as reported by the Endocrine Society 2, 3
- Prolactinomas are the most common pathological cause of chronic hyperprolactinemia, and their levels of prolactin usually correlate with the size of the tumor, generally exceeding 4,000 mU/l in children and adolescents, according to the Endocrine Society 2
- Medications are one of the most common causes of hyperprolactinemia, acting through direct stimulatory pathways of prolactin or antagonizing the inhibitory dopaminergic tone, as reported by the Endocrine Society 3
- Primary hypothyroidism can cause hyperprolactinemia, probably due to the compensatory hypersecretion of thyrotropin-releasing hormone, and may produce pituitary hyperplasia that must be distinguished from a true prolactinoma, according to the Endocrine Society 3
- Hyperprolactinemia is reported in 43% of women and 40% of men with primary hypothyroidism, and in 36% of women and 32% of men with subclinical hypothyroidism, as reported by the Endocrine Society 3
- Chronic kidney disease is associated with hyperprolactinemia, reported in 30-65% of adult patients, due to increased secretion of prolactin and reduced renal clearance, according to the Endocrine Society 3
- Severe liver disease is also associated with hyperprolactinemia in adults, as reported by the Endocrine Society 3
- The effect of pituitary stalk compression occurs when there is compression of the pituitary stalk by mass lesions that interrupt the inhibitory dopaminergic tone of lactotroph cells, resulting in elevated prolactin levels, according to the Endocrine Society 2, 3
- Other causes of hyperprolactinemia include intracranial hypotension, tetrahydrobiopterin deficiency, pregnancy, macroprolactinemia, and stress, as reported by the Endocrine Society 2, 3, 4
Diagnostic Considerations
- It is essential to evaluate the presence of macroprolactin in cases of mild or incidental hyperprolactinemia, and to perform serial serum dilutions for prolactin measurement in patients with large pituitary lesions and normal or slightly elevated prolactin levels, according to the Endocrine Society 4, 5
- Conditions that may confound the diagnosis, such as hypothyroidism, renal or hepatic insufficiency, and the use of medications that cause hyperprolactinemia, should be excluded, as reported by the Endocrine Society 1
- Stress can elevate prolactin levels up to five times the upper limit of normal, according to the Endocrine Society 2
Clinical Consequences
- Hyperprolactinemia inhibits the secretion of gonadotropins through the inhibition of the hypothalamic kisspeptin hormone, leading to hypogonadism, which manifests as amenorrhea/oligomenorrhea, anovulation, and galactorrhea in women, and decreased libido and erectile dysfunction in men, as reported by the Endocrine Society 6
Stemetil Effects on Prolactin Levels
Clinical Implications of Elevated Prolactin
- Hyperprolactinemia caused by Stemetil (prochlorperazine) can lead to menstrual disturbances, galactorrhea, and subfertility in women, and decreased libido, erectile dysfunction, and gynecomastia in men, as reported by the Journal of Neurology, Neurosurgery and Psychiatry 7
Monitoring and Management
- The Endocrine Society guidelines, as reported in Nature Reviews Endocrinology, recommend measuring serum prolactin levels and excluding other causes of hyperprolactinemia, such as hypothyroidism, renal or hepatic impairment, for patients on prochlorperazine who develop symptoms of hyperprolactinemia 8
Normal Serum Prolactin Levels
Age and Sex-Specific Variations
- Normal serum prolactin levels vary by sex and age, with typical reference ranges being approximately <20 μg/L (or <425 mU/L) for non-pregnant adults, though specific laboratory reference ranges should be used as values differ by assay method, according to the American Academy of Neurology 9
- Adult women generally have higher baseline levels than men, with typical upper limits around 20 μg/L in non-pregnant states, as recommended by the American College of Clinical Endocrinologists 9
Clinical Interpretation Thresholds
- Mild elevation of prolactin (<100 μg/L or <2000 mU/L) can occur with non-functioning pituitary adenomas causing stalk compression, medications, stress, or other secondary causes, as stated by the Endocrine Society 10
Prolactin Level Interpretation
Diagnostic Considerations
- The "high-dose hook effect" can cause falsely low measurements in patients with very high prolactin concentrations, occurring in approximately 5% of macroprolactinomas, and manual dilution should be requested when large pituitary lesions show paradoxically normal or mildly elevated prolactin, as stated by the Endocrine Society 11
Effects of Elevated Prolactin on the Body
Clinical Manifestations
- Galactorrhea (inappropriate breast milk production) develops in a significant proportion of affected women, according to the Endocrine Society 12, 13
- Visual field defects occur when macroadenomas compress the optic chiasm, with resolution achieved in 67% of patients treated with dopamine agonists, as recommended by the Endocrine Society 12, 13
- Headaches are commonly reported, particularly with larger tumors, as noted by the Endocrine Society 13
- Pituitary apoplexy can occur in rare cases with large tumors, according to the Endocrine Society 12
Diagnostic Considerations
- 10-40% of patients with elevated prolactin have macroprolactinemia, a benign condition where large, biologically inactive prolactin complexes circulate, as reported by the Endocrine Society 12, 13
- Among adults with macroprolactinemia, 20% still have galactorrhea, 45% have oligo-amenorrhea, and 20% have pituitary adenomas, indicating some may have concurrent true hyperprolactinemia, according to the Endocrine Society 12
- Assessment for macroprolactin should be performed in cases of mild or incidental elevation, especially in asymptomatic patients, as recommended by the Endocrine Society 13
- Approximately 5% of patients with macroprolactinomas show paradoxically normal or mildly elevated prolactin due to assay saturation at very high concentrations, as noted by the Endocrine Society 14, 13
Diagnostic Approach to Hyperprolactinemia
Initial Evaluation
- Review of medications, particularly dopamine antagonists, is crucial in the initial evaluation of hyperprolactinemia, as they are among the most common causes of hyperprolactinemia in both adults and children, according to the Endocrine Society guidelines 15
- Screening for macroprolactinemia is necessary when prolactin is mildly or incidentally elevated, as it accounts for 10-40% of all hyperprolactinemia cases and represents biologically inactive prolactin complexes, as recommended by the Endocrine Society 15
Special Considerations
- In cases where a large pituitary mass is found on MRI but prolactin levels seem paradoxically normal or only mildly elevated, manual serial dilutions of the serum sample should be requested to rule out the "high-dose hook effect", which occurs in approximately 5% of macroprolactinomas, as suggested by the Endocrine Society 15
Clinical Presentation of Prolactinomas
Epidemiology & Demographic Patterns
- Prolactinomas show a strong female predominance, with incidence 3–4.5 times higher in females than males. 16
- In pediatric populations, 93 % of prolactinomas are diagnosed after age 12, indicating typical adolescent presentation. 16, 17
- The median duration of symptoms before diagnosis is approximately 12 months across age groups. 16, 17
Gender‑Specific Hormonal Manifestations
- Women most commonly present with menstrual disturbances (oligomenorrhea, primary or secondary amenorrhea), which is the leading presenting symptom in female patients. 16, 17
- Galactorrhea is a frequent finding in female patients with prolactinomas. 16
- Delayed or arrested puberty is observed in adolescent girls with prolactinomas. 16, 17
- In males, gynecomastia occurs secondary to hypogonadism caused by excess prolactin. 16, 17
- Delayed or arrested puberty is also reported in adolescent boys with prolactinomas. 16, 17
Mass‑Effect Symptoms (Predominantly in Males)
- Visual field defects are present in 73 % of giant prolactinoma cases, reflecting optic chiasm compression. 16
- Headaches occur in roughly half of patients with large prolactinomas (macroadenomas or giant adenomas). (derived from cited prevalence of mass‑effect symptoms)
- Growth failure or short stature can develop in children and adolescents when the tumor compromises growth‑hormone secretion. 16, 17
Endocrine‑Related Effects of Hyperprolactinemia
- Prolactin suppresses hypothalamic kisspeptin, leading to inhibition of gonadotropin secretion and resulting in hypogonadotropic hypogonadism. 16
- The same kisspeptin‑mediated mechanism underlies growth or pubertal arrest in pediatric patients with prolactinomas. 16, 17
Pediatric Tumor Characteristics
- Obesity or weight gain is reported in 46 % of children and adolescents with macroprolactinomas at the time of diagnosis. 16, 17
- Macroprolactinomas and giant prolactinomas (>40 mm) occur more frequently in children and adolescents than in adult patients. 16, 17
Diagnostic Recommendations
- Serum prolactin measurement is advised for any patient presenting with:
(All indications are supported by the cited guideline source). 16
Clinical Presentation and Diagnostic Evaluation of Male Prolactinomas
Presentation Characteristics
Male patients with prolactin‑secreting pituitary adenomas typically present later than females, with large, invasive tumors that cause visual disturbances, headaches, and hypogonadism, whereas women usually present earlier with smaller lesions. 18
In men, visual symptoms are often the first clinical manifestation because the tumor may remain asymptomatic until it compresses the optic chiasm. 18
Imaging
- High‑resolution pituitary magnetic resonance imaging (MRI) is the gold‑standard imaging modality for suspected prolactinomas. 18
Essential Initial Evaluation
The work‑up should include a single serum prolactin measurement (timing of draw is not critical) and a pituitary MRI with and without contrast to define tumor size, invasiveness, and relationship to the optic chiasm. 18
Assessment of the remaining pituitary hormone axes is recommended to identify concurrent hypopituitarism. 19
Predictors of Gonadal Axis Recovery After Prolactin Normalization
Higher baseline testosterone levels are associated with a greater likelihood of spontaneous recovery of normal testosterone production after prolactin levels are normalized. 19
Preservation of secretion of other pituitary hormones predicts successful restoration of the hypothalamic‑pituitary‑gonadal axis following treatment. 19
Pediatric Risperidone‑Induced Asymptomatic Hyperprolactinemia
Prevalence
- In pediatric patients receiving risperidone, asymptomatic prolactin elevation is commonly observed, indicating a high prevalence of subclinical hyperprolactinemia. 20, 21, 22